Provided by Tiger Trade Technology Pte. Ltd.

Charles River Laboratories

288.43
-11.8750-3.95%
Volume:406.15K
Turnover:118.58M
Market Cap:13.77B
PE:-59.09
High:296.88
Open:296.88
Low:288.43
Close:300.30
52wk High:333.30
52wk Low:146.20
Shares:47.74M
Float Shares:47.20M
Volume Ratio:0.83
T/O Rate:0.86%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.8814
EPS(LYR):-2.9122
ROE:-7.52%
ROA:4.11%
PB:4.85
PE(LYR):-99.04

Loading ...

Unicycive Therapeutics Receives Complete Response Letter from FDA Regarding Resubmitted Oxylanthanum Carbonate (OLC) New Drug Application (NDA)

GlobeNewswire
·
Jun 30

Charles River Laboratories International Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jun 30

Charles River Laboratories International Inc. Stock Underperforms Friday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Jun 27

Lantheus Receives Complete Response Letter from FDA for LNTH-2501 (Ga 68 edotreotide)

GlobeNewswire
·
Jun 27

Charles River Laboratories International Inc. Stock Advances 5.2%, Outperforms Peers

Dow Jones
·
Jun 26

BTIG’s Brisebois Reiterates Buy on Aquestive Therapeutics, Calling Sell-Off Overdone After SPRY Payer Update and Highlighting Limited Scope of FDA CRL for Anaphylm

TIPRANKS
·
Jun 26

Movement Alert|Charles River Laboratories Rises 5.09% in Regular Trading, Morgan Stanley Upgrade and Positive Annual Report Signals Continue to Drive Momentum

Market Focus
·
Jun 25

Tanvex's US Unit Receives FDA Nod for TX05 Cancer Drug Biosimilar; Shares Drop 10%

MT Newswires Live
·
Jun 25

Charles River Laboratories International Inc. Stock Advances 8.3%, Outperforms Peers

Dow Jones
·
Jun 25

Movement Alert|Charles River Laboratories Rises 6.55% in Regular Trading, Morgan Stanley Upgrade and Positive Earnings Conference Signals Drive Rally

Market Focus
·
Jun 24

Charles River Laboratories International Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Jun 23

Achieve Life Sciences CRL from FDA cites deficiencies at manufacturing facility

TIPRANKS
·
Jun 22

Achieve Life Sciences Receives Complete Response Letter from FDA for Cytisinicline NDA

GlobeNewswire
·
Jun 22

Charles River Laboratories International Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jun 19

Charles River Laboratories International - Announces Collaboration With Lilly Tunelab

THOMSON REUTERS
·
Jun 18

Charles River teams with Lilly TuneLab to provide nonclinical testing for AI-driven drug discovery platform

Reuters
·
Jun 18

Press Release: Grace Therapeutics Announces 2026 Fiscal Year-End Financial Results, Provides Business Update

Dow Jones
·
Jun 18

Rothschild & Co Redburn Adjusts Charles River Laboratories International PT to $241 From $230, Maintains Buy Rating

MT Newswires Live
·
Jun 18

Charles River Laboratories Shares Rise After Morgan Stanley Upgrade

MT Newswires Live
·
Jun 18

Charles River Labs Raised to Overweight From Equal-Weight by Morgan Stanley

Dow Jones
·
Jun 17